Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

King Star Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$96M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 4
Key employees 1

Areas of investment

  • Medical
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
Summary

We also calculated 1 valuable employee in our database.

Deals in the range of more than 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The important activity for fund was in 2018. Comparing to the other companies, this King Star Capital performs on 21 percentage points more the average number of lead investments. The top amount of exits for fund were in 2019.

Among the most popular portfolio startups of the fund, we may highlight CStone Pharmaceuticals, MabSpace Biosciences, Gracell Biotechnologies. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical.

The typical case for the fund is to invest in rounds with 6 participants. Despite the King Star Capital, startups are often financed by WuXi Healthcare Ventures, F-Prime Capital, Oriza Seed Capital (Oriza Yuandian). The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, Lilly Asia Ventures, YF Capital (Yunfeng Capital). In the next rounds fund is usually obtained by 6 Dimensions Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of King Star Capital:
Typical Co-investors
King Star Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after King Star Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abacus Capital Group New York, New York, United States
Caligan Partners -
Chengdu Saide Gaoxin Chengdu, China, Sichuan
Gaopeng Gong Chuang China, Guangdong, Shenzhen
HEM ANGELS India, Maharashtra, Mumbai
Heze Investment China, Heze, Shandong
Hwa Create Beijing, China, Haidian
Investment and Economic Development Bank of Rheinland-Pfalz -
MMC Technology Ventures -
Naftali Investments -
NH Investimentos Brazil, São Paulo, Sao Paulo
PTC Therapeutics New Jersey, South Plainfield, United States
Quartz -
REA Group Australia, Melbourne, Victoria
Scenic Investments -
Syllex -
TED Beteiligungs GmbH -
Vento Security Holdings Massachusetts, Nantucket, United States
Yongda Investment Group China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ronovo Surgical

Health Care
Medical Device
Robotics
$46M14 Jun 2024 Shanghai, China

Gracell Biotechnologies

Biotechnology
Health Care
Medical
$100M28 Oct 2020 Gusu District, Jiangsu, China

Gracell Biotechnologies

Biotechnology
Health Care
Medical
$85M25 Feb 2019 Gusu District, Jiangsu, China

MabSpace Biosciences

Biotechnology
Health Diagnostics
Medical
$40M11 May 2018 China, Jiangsu

CStone Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$260M09 May 2018 China, Jiangsu

Adagene

Biotechnology
Medical
Therapeutics
$50M27 Mar 2018 China, Jiangsu

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent King Star Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 96M
Peak activity year 2018
Lead investments 0
Follow on index 0.17
Exits 4
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ronovo Surgical

Health Care
Medical Device
Robotics
$46M14 Jun 2024 Shanghai, China

Gracell Biotechnologies

Biotechnology
Health Care
Medical
$100M28 Oct 2020 Gusu District, Jiangsu, China

Gracell Biotechnologies

Biotechnology
Health Care
Medical
$85M25 Feb 2019 Gusu District, Jiangsu, China

MabSpace Biosciences

Biotechnology
Health Diagnostics
Medical
$40M11 May 2018 China, Jiangsu

CStone Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$260M09 May 2018 China, Jiangsu

Adagene

Biotechnology
Medical
Therapeutics
$50M27 Mar 2018 China, Jiangsu
Crunchbase icon

Content report

The following text will be sent to our editors: